At the news
? NEUTRALIMPACT 4/10 S-3 filed Nov 12, 2026 at 16:48 ET
Equillium filed an S-3 registration statement to register 35,087,717 shares of common stock for resale by selling stockholders who purchased shares and pre-funded warrants in a private placement that closed on October 26, 2026. The company will not receive any proceeds from the resale. The filing is a contractual obligation under a Registration Rights Agreement, not a new capital raise.
- S-3 registers 35,087,717 shares for resale by selling stockholders, including 20,130,457 shares issuable upon exercise of pre-funded warrants
- Shares were sold in a private placement at $0.57 per share (common) and $0.5699 per warrant, with aggregate gross proceeds of approximately $50.0 million
- The company will not receive any proceeds from the resale under this prospectus
- Filing is required under a Registration Rights Agreement dated August 12, 2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access